Ban & Monetization Policy
MyLiveRoom Rewards Program Rules & Eligibility
0 Комментарии
0 Поделились
2Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Cancer Biological Therapy Market : Size, Share, and Future Growth 2025 –2032"Executive Summary Cancer Biological Therapy Market Opportunities by Size and Share CAGR Value Data Bridge Market Research analyses a growth rate in the global cancer biological therapy market in the forecast period 2022-2029. The expected CAGR of global cancer biological therapy market is tend to be around 8% in the mentioned forecast period. The market was valued...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Cancer Radiation Therapy Market Report Scope By Business Market InsightsThe Cancer Radiation Therapy Market Report scope delivers a comprehensive, multi-dimensional analytical framework covering the full breadth of the global cancer radiation therapy industry, encompassing market sizing and forecasting, detailed segmentation analysis across type, cancer type, and end user, competitive landscape assessment, regional and country-level performance, and an in-depth...0 Комментарии 0 Поделились 326 Просмотры 0 предпросмотр
-
Cancer Radiation Therapy Market Size, Share, and Trends 2025–2033According to the Business Market Insights The Global Cancer Radiation Therapy Market is poised for significant expansion, driven by the increasing global burden of cancer and rapid technological innovations in oncology treatment. According to market estimates, the cancer radiation therapy market was valued at approximately US$ 57.88 billion in 2024 and is projected to reach US$ 136.16 billion...0 Комментарии 0 Поделились 200 Просмотры 0 предпросмотр
-
Cancer Targeted Therapy Market Report Scope By Business Market InsightsThe Cancer Targeted Therapy Market report by Business Market Insights, covering the complete Cancer Targeted Therapy Market Report scope, delivers a comprehensive, rigorously structured, and data-driven analysis of the global cancer targeted therapy industry spanning monoclonal antibodies, tyrosine kinase inhibitors, immune checkpoint inhibitors, cancer vaccines, gene therapy, and other therapy...0 Комментарии 0 Поделились 373 Просмотры 0 предпросмотр
-
Intratumoral Cancer Therapy Market Share, Size and Competitive Landscape Report 2028Future of Intratumoral Cancer Therapy Market: Key Dynamics, Size & Share Analysis The Global Intratumoral Cancer Therapy market is projected to grow at a CAGR of around 11.1% during the forecast period, i.e., 2023-28. The growing prevalence of cancer & rising demand for targeted & personalized medicine for treatment is driving the requirement for this therapy in the...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Salivary Gland Cancer Treatment Market: Targeted Therapy Pipeline, Precision Oncology Strategies"Executive Summary Salivary Gland Cancer Treatment Market Size and Share Analysis Report The global salivary gland cancer treatment market size was valued at USD 1.78 billion in 2024 and is expected to reach USD 3.27 billion by 2032, at a CAGR of 7.90% during the forecast period The global Salivary Gland Cancer Treatment Market research report has...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Advances in Oncology Research Driving the Metastatic Solid Tumors MarketComprehensive Outlook on Executive Summary Metastatic Solid Tumors Market Size and Share CAGR Value Data Bridge Market Research analyses a growth rate in the global metastatic solid tumors market in the forecast period 2022-2029 Metastatic Solid Tumors Market research report unearths different industry verticals such as company profile, contact details of manufacturer, product...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Burkitt Lymphoma Therapeutics Market Size, Share & Growth Analysis Report 2025–2034Get Your Sample Report Here: https://reedintelligence.com/market-analysis/burkitt-lymphoma-therapeutics-market/request-sample Buy Now: https://reedintelligence.com/market-analysis/burkitt-lymphoma-therapeutics-market Burkitt Lymphoma Therapeutics Market Overview The global Burkitt Lymphoma Therapeutics Market is experiencing significant growth due to the increasing prevalence of lymphoma...0 Комментарии 0 Поделились 278 Просмотры 0 предпросмотр
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр
-
Emerging Trends Influencing the Antibody Drug Conjugates MarketAsia-Pacific is expected to witness rapid growth in the coming years due to increasing healthcare investments and expanding pharmaceutical manufacturing capabilities. Countries like China and India are emerging as important research hubs. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...0 Комментарии 0 Поделились 6Кб Просмотры 0 предпросмотр
-
Future Market Potential of Chemotherapy-Induced Peripheral Neuropathy TreatmentsThe global chemotherapy-induced peripheral neuropathy market size is projected to grow from US$ 1.01 billion in 2025 to approximately US$ 1.67 billion by 2034, reflecting a steady expansion. The market is anticipated to register a compound annual growth rate (CAGR) of around 5.71% during the forecast period, highlighting increasing investments in oncology supportive care. The...0 Комментарии 0 Поделились 5Кб Просмотры 0 предпросмотр
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Global CAR-T Cell Therapy Market Growth at 17.5% CAGR Through 2030Increasing research and development activities in cell-based therapies are supporting the expansion of the CAR-T cell therapy market. Pharmaceutical and biotechnology companies are investing heavily in clinical trials and advanced technologies. These efforts are accelerating the development of new and effective cancer treatments. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030...0 Комментарии 0 Поделились 5Кб Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek
